Fathi-Kazerooni, Mina
Fattah-Ghazi, Samrand
Darzi, Maryam
Makarem, Jalil
Nasiri, Reza
Salahshour, Faeze
Dehghan-Manshadi, Seyed Ali
Kazemnejad, Somaieh
Funding for this research was provided by:
The Avicenna Research Institute (99/3436)
Zayabiotech Company
Article History
Received: 26 October 2021
Accepted: 17 February 2022
First Online: 7 March 2022
Declarations
:
: All the procedures in this clinical trial study were conducted according to Good Clinical Practice (GCP) or GMP guidelines approved by the Biomedical Research Ethics Committee of Academic Center for Education, Culture, and Research (Code:IR.ACECR.REC.1399.005). Written informed consent was obtained from each patient or the patient’s legally authorized surrogate before the conduct of study-specific procedures.
: Not relevant.
: The authors declare that they have no competing interests.